Curanex Pharmaceuticals (CURX) Shares Outstanding (2024 - 2025)
Curanex Pharmaceuticals' (CURX) quarterly Shares Outstanding (Entity) came in at $28.3 million in Q4 2025, up 113.75% YoY from $13.3 million in Q4 2024, and little changed on a QoQ basis from $28.3 million in Q3 2025.
Curanex Pharmaceuticals (CURX) Shares Outstanding (2024 - 2025) Analysis & Trends
Curanex Pharmaceuticals (CURX) has 2 years of Shares Outstanding (Entity) data on file, last reported at $28.3 million in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 113.75% year-over-year to $28.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $28.3 million (up 113.75% YoY) and the FY2025 annual result came in at $28.3 million, up 113.75% from the prior year.
- Shares Outstanding (Entity) was little changed at $28.3 million in Q4 2025, from $28.3 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $28.3 million in Q3 2025 to a low of $2.4 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Curanex Pharmaceuticals | 6.02 Mn | 1.02 Mn | - | 1.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 25.50 Mn |
| Sep 30, 2025 | 25.60 Mn |
| Jun 30, 2025 | 24.00 Mn |
| Dec 31, 2024 | 13.26 Mn |
| Sep 30, 2024 | 2.40 Mn |